Niemann-pick Disease
Niemann-Pick Disease, abbreviated as NP, is a type of rare genetic disorder that affects the body's metabolism. It is one of the neurodegenerative disorders that progressively affect the nervous system's functioning. NP causes a buildup of fatty substances, notably cholesterol and lipids, in various organs of the body such as the liver, spleen, and bone marrow, among others. The accumulation causes these organs' enlargement, eventually leading to organ failure. Brain cells, too, can be affected, especially in infants and children, leading to mental and neurological impairment. NP has four different types, each caused by a deficiency in a particular enzyme that is necessary for the breakdown of fatty substances. The type of NP is characterized by the age of onset, its symptoms, and its severity. Currently, there is no cure for NP. However, treatments and therapies can help alleviate and manage some symptoms. Enzyme replacement therapy (ERT) is one of the treatments used today. Gene therapy is also being researched as a potential future option for treating NP. Research and therapy for Niemann-Pick disease are extremely important due to its rarity and devastating effects. At present, therapies are available that can help patients manage their symptoms and improve their quality of life. Ongoing research aims to expand on this knowledge and come up with more effective treatments that may one day provide a cure for this disease.
← Journal of Neurological Research And Therapy